Recurrence: all 3,523 studies

Page 31 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• Estimating the Risk of Plasmodium Vivax Relapses in AfghanistanCompletedNCT01178021Phase 4
• Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian CarcinomaTerminatedNCT01177501Phase 1
• New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and NeuroblastomaWithdrawnNCT01174537Phase 1/2
• Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)CompletedNCT01172548Phase 2
• Effect of Tranexamic Acid on Prevention of Recurrence of HemoptysisWithdrawnNCT01167764Phase 3
• Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT01166737Not applicable
• Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck CancersCompletedNCT01166542Phase 3
• Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to LenalidomideCompletedNCT01166113Phase 1/2
• Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid TumorsCompletedNCT01165385Phase 1
• Fibrin Glue vs. Suture in Pterygium SurgeryCompletedNCT01158014Not applicable
• Early Re-Intervention Experiment 2CompletedNCT01153594Phase 3
• MAPS Group Therapy Model for Bipolar DisorderCompletedNCT01152034Not applicable
• Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous HemorrhageStatus unknownNCT01151722Phase 2
• Follow-up Study of Transcranial Direct Current Stimulation to Treat Major Depressive DisorderCompletedNCT01149213Phase 2/3
• A Study of AT9283 in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01145989Phase 2
• The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression RelapseCompletedNCT01145872Phase 3
• Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia RepairCompletedNCT01141335Phase 4
• Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS TumoursCompletedNCT01135563Phase 1
• Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedNCT01134341Phase 1
• PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & OfatumumabWithdrawnNCT01131247Phase 2
• Prevention of Postpartum Smoking Relapse in Mothers of Infants in the Neonatal Intensive Care Unit (NICU)CompletedNCT01131156Not applicable
• Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative SurgeryStatus unknownNCT01125488Phase 3
• Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT01125020Not applicable
• A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis CCompletedNCT01121731Phase 1/2
• Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma PatientsTerminatedNCT01116128Phase 2
• A Panobinostat PresurgeryWithdrawnNCT01115036Phase 2
• The Lung Attack Alert StudyCompletedNCT01107613Not applicable
• A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid TumorsCompletedNCT01106508Phase 1
• Prospective Study of the Outcomes of the Surgical Treatment of Deeply Infiltrating EndometriosisStatus unknownNCT01105897
• Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein PurpuraStatus unknownNCT01104428Phase 2
• Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.CompletedNCT01101776
• A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple MyelomaTerminatedNCT01101594Phase 1/2
• Non Operative Treatment for Acute AppendicitisCompletedNCT01096927Phase 4
• Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal MetastasesWithdrawnNCT01095523Phase 2
• Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid MalignanciesCompletedNCT01094860Phase 1
• Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional TherapyCompletedNCT01094405Phase 2
• The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate CancerStatus unknownNCT01089881
• Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
• Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT01086735Phase 1/2
• Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal CarcinomaStatus unknownNCT01086488Phase 2
• Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid TumorsTerminatedNCT01081808Phase 1
• Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung CancerCompletedNCT01079481Phase 1
• Emergency Department (ED)-Directed Interventions to Improve Asthma OutcomesCompletedNCT01079000Not applicable
• Incidence of Vivax Along the Thai Burma BorderCompletedNCT01076868Not applicable
• Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years PeriodCompletedNCT01076595
• Study on the Treatment of Vivax MalariaCompletedNCT01074905Phase 3
• Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044)CompletedNCT01071304Phase 1
• Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient CohortCompletedNCT01070719
• Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)CompletedNCT01068392Phase 2
• The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) TreatmentCompletedNCT01067573
• Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal TranslocationCompletedNCT01058434Phase 2
• Compensatory Strategies Applied to Cognitive Impairment in SchizophreniaCompletedNCT01055509Not applicable
• Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerCompletedNCT01053494Not applicable
• Perifosine With Temsirolimus for Recurrent Pediatric Solid TumorsCompletedNCT01049841Phase 1
• An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid TumorsCompletedNCT01040312
• Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid LeukemiaStatus unknownNCT01039363Phase 2
• Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIALStatus unknownNCT01039298Phase 3
• Measuring Distress Tolerance With Functional MRICompletedNCT01038232
• Study of Smoking AbstinenceCompletedNCT01035632
• A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)TerminatedNCT01035216Phase 1
• A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid LeukemiaTerminatedNCT01034410Phase 2
• A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT01033292Phase 2
• A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian CancerCompletedNCT01033123Phase 2
• Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's LymphomaTerminatedNCT01032148Phase 1
• Pexy Versus Non-pexy for Full Thickness Rectal ProlapseCompletedNCT01022034Phase 3
• PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated PatientsCompletedNCT01020604
• Natural History of Sigmoid Diverticulitis: The Geneva Cohort StudyStatus unknownNCT01015378
• Third-line Therapy of Multiple Myeloma a Prospective Phase I /II TrialStatus unknownNCT01010243Phase 1/2
• Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular TechniqueCompletedNCT01008657Not applicable
• A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior TreatmentCompletedNCT01007292Phase 2
• Markers of Response to Intravesical Bladder Cancer TherapyCompletedNCT01007058
• Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band ImagingCompletedNCT01004211Not applicable
• Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic LeukemiaCompletedNCT00995137Phase 1
• Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
• Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneCompletedNCT00993694
• IMGN901 in Combination With Lenalidomide and DexamethasoneCompletedNCT00991562Phase 1
• Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic MalignancyCompletedNCT00990587Phase 1
• Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes InfusionCompletedNCT00987987Phase 1/2
• Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid RecurrenceTerminatedNCT00987545Phase 2
• Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)CompletedNCT00981708Phase 1/2
• Neurotropic Melanoma of the Head and NeckCompletedNCT00975520Not applicable
• Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)TerminatedNCT00968331Phase 2
• Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous ThromboembolismCompletedNCT00967304Phase 4
• Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid TumorsTerminatedNCT00966498Not applicable
• Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyTerminatedNCT00963495Phase 1
• Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric CancerStatus unknownNCT00961077Phase 2
• Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00957736
• The Efficacy of Human Acellular Dermal Matrix in the Treatment of Anal FistulaStatus unknownNCT00951002
• Conjunctival Autologous Transplantation Using Fibrin Glue in Primary PterygiaCompletedNCT00949728Not applicable
• Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerTerminatedNCT00949052
• Online and Narrative Interventions for Advanced Cancer PatientsCompletedNCT00948207Not applicable
• Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) MethylprednisoloneTerminatedNCT00947895Phase 2/3
• Benign Acute Pericarditis: Brief Versus Longer Treatment Using AspirinTerminatedNCT00946907Phase 4
• Temsirolimus in Recurrent Primary Central Nervous System (CNS) LymphomaStatus unknownNCT00942747Phase 2
• Proof of Concept Study to Investigate the Recurrence of Acne Post IsotretinoinCompletedNCT00939133Phase 4
• Understanding the Impact of Meditative Homework on Metacognitive Processes in the Context of Mindfulness Based Cognitive Therapy (MBCT)CompletedNCT00938873
• Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaTerminatedNCT00933985Phase 1
• Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid TumorsCompletedNCT00925275Phase 1
• A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00923182Phase 1
• Study of Anatomic Nerve Sparing Radical Perineal ProstatectomyWithdrawnNCT00922818

← Recurrence overview